Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters - a pilot study.

"Conflict of interest SB is co-owner of exago.ml, a geoanalytics-focused machine learning company. SH has received speaker’s honoraria from Alexion, argenx, UCB and Roche and honoraria for attendance at advisory boards from Alexion, argenx and Roche, and is member of the medical advisory board of the German Myasthenia Society. SL has received speaker’s honoraria from Alexion, argenx, Hormosan and UCB, and honoraria for attendance of advisory boards from Alexion, argenx, Biogen, HUMA, UCB and Roche. FSt received speaker’s honoraria and honoria for attendance of advisory boards from Alexion, argenx and UCB Pharma. MS received speaker’s honoraria for attendance at patient events from argenx and Alexion. AM has received speaker’s honoraria, consulting fees or (institutional) financial research support from Alexion Pharmaceuticals Inc., Argenx, Grifols SA, Hormosan Pharma GmbH, Janssen, Octapharma, and UCB Pharma, and is chairman of the medical advisory board of the German Myasthenia Society. PM has been on the board of HealthNextGen. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"The author(s) declare financial support was received for the publication of this article. This study did not receive dedicated funding. PM is Einstein Junior Fellow, and AB is Einstein Visiting Fellow, both funded by the Einstein Foundation Berlin. PM acknowledges funding support by the Einstein Foundation Berlin (EJF-2020-602; EVF-BUA-2022-694), PM and AB acknowledge joint funding by the Einstein Foundation Berlin (EVF-2021–619), and the Leducq Foundation for Cardiovascular and Neurovascular Research (Consortium International pour la Recherche Circadienne sur l’AVC). The authors acknowledge financial support for open access publication from the Open Access Publication Fund of Charité - Universitätsmedizin Berlin. The funding organizations did not play any role in the design of the study, preparation, review, approval of the manuscript, or decision to submit the manuscript for publication."